You are here

  • Home
  • Archive
  • Volume 97, Issue 4
  • An alarming high prevalence of resistance-associated mutations to macrolides and fluoroquinolones in Mycoplasma genitalium in Belgium: results from samples collected between 2015 and 2018

Article info

Article menu
Download PDFPDF
Epidemiology
Original research
An alarming high prevalence of resistance-associated mutations to macrolides and fluoroquinolones in Mycoplasma genitalium in Belgium: results from samples collected between 2015 and 2018

Authors

  1. Correspondence to Dr Irith De Baetselier, Department of Clinical Sciences, Institute of Tropical Medicine, Antwerpen 2000, Belgium; idebaetselier{at}itg.be
View Full Text

Citation

De Baetselier I, Kenyon C, Vanden Berghe W, et al
An alarming high prevalence of resistance-associated mutations to macrolides and fluoroquinolones in Mycoplasma genitalium in Belgium: results from samples collected between 2015 and 2018
Sexually Transmitted Infections 2021;97:297-303.

Publication history

  • Received March 24, 2020
  • Revised July 2, 2020
  • Accepted July 5, 2020
  • First published August 7, 2020.
Online issue publication 
May 11, 2023

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.